Canadian commercial dermatology company Crescita Therapeutics has named its Corporate Controller Ms. Muneerah Kanji as Interim Chief Financial Officer.
Kanji will replace Mario Laflamme, Crescita said on Friday, as he has resigned for health-related family reasons. Crescita said it is looking for a new CFO.
“Ms. Kanji brings a wealth of global financial and operations experience to Crescita and we look forward to her input in her new role,” said Dan Chicoine, Crescita’s Executive Chairman and Interim Chief Executive Officer. “We appreciate Mr. Laflamme’s efforts and contributions to the Company and wish him well.”